Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Debt to Equity (2017 - 2025)

Selectis Health's Debt to Equity history spans 12 years, with the latest figure at -$5.36 for Q3 2025.

  • For Q3 2025, Debt to Equity rose 17.08% year-over-year to -$5.36; the TTM value through Sep 2025 reached -$5.36, up 17.08%, while the annual FY2024 figure was -$5.65, 53.91% up from the prior year.
  • Debt to Equity for Q3 2025 was -$5.36 at Selectis Health, down from -$1.88 in the prior quarter.
  • Across five years, Debt to Equity topped out at $53.27 in Q3 2023 and bottomed at -$12.26 in Q4 2023.
  • The 5-year median for Debt to Equity is $2.28 (2021), against an average of $6.12.
  • The largest annual shift saw Debt to Equity skyrocketed 5945.65% in 2023 before it tumbled 219.78% in 2024.
  • A 5-year view of Debt to Equity shows it stood at $2.28 in 2021, then soared by 1591.55% to $38.51 in 2022, then tumbled by 131.84% to -$12.26 in 2023, then surged by 53.91% to -$5.65 in 2024, then grew by 5.23% to -$5.36 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Debt to Equity are -$5.36 (Q3 2025), -$1.88 (Q2 2025), and -$2.0 (Q1 2025).